Stock listing
LSE:0QNA Basilea Pharmaceutica AG Share Price
UK listing (LSE) of Basilea Pharmaceutica AG · home listing SIX Swiss:BSLN
Follow Basilea Pharmaceutica AG into a list and get an email when it puts out news.
Share price · LSE:0QNA
71.30 CHF -0.70 (-1.0%)
Close on Nov 18, 2026
- Day range
- 71.30 – 72.75 CHFNov 18, 2026
- Volume
- 2,104 sharesNov 18, 2026
- 52-week range
- 46.94 – 74.50 CHFLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- 643,069 CHFMedian day 1,914 shares · last 3 months, Aug 18, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:BSLN · Home | 71.50 CHF | -0.40 (-0.6%) | 23,748 | 71.80 | 73.00 | 71.30 | 71.90 | Close on Nov 18, 2026 |
| LSE:0QNA | 71.30 CHF | -0.70 (-1.0%) | 2,104 | 72.75 | 72.75 | 71.30 | 72.00 | Close on Nov 18, 2026 |
| OTC:BPMUF | $84.00 USD | +7.75 (+10.2%) | 10 | $84.00 | $84.00 | $84.00 | $76.25 | Close on Nov 11, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 6, 2026 · LSE:0QNA · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 71.50 | +0.10 | +0.1% | 69.60 | 71.50 | 69.60 | 1,757 | |
| 71.40 | -3.10 | -4.2% | 74.00 | 74.00 | 71.40 | 3,098 | |
| 74.50 | +1.30 | +1.8% | 73.30 | 74.50 | 72.90 | 4,772 | |
| 73.20 | +3.40 | +4.9% | 72.60 | 73.80 | 72.60 | 221 | |
| 69.80 | -1.10 | -1.6% | 70.80 | 70.80 | 69.80 | 1,246 | |
| 70.90 | -2.20 | -3.0% | 71.40 | 71.40 | 70.60 | 438 | |
| 73.10 | -0.60 | -0.8% | 73.05 | 73.50 | 72.90 | 73 | |
| 73.70 | +1.20 | +1.7% | 72.00 | 74.30 | 72.00 | 217 | |
| 72.50 | +3.20 | +4.6% | 73.60 | 73.60 | 71.00 | 990 | |
| 69.30 | +0.45 | +0.7% | 69.40 | 69.80 | 69.30 | 756 | |
| 68.85 | +0.05 | +0.1% | 68.30 | 69.60 | 68.30 | 995 | |
| 68.80 | +0.40 | +0.6% | 68.00 | 69.30 | 67.90 | 1,499 | |
| 68.40 | +0.55 | +0.8% | 67.15 | 68.40 | 67.15 | 276 | |
| 67.85 | +1.45 | +2.2% | 67.90 | 67.90 | 66.20 | 1,255 | |
| 66.40 | +0.50 | +0.8% | 65.55 | 66.40 | 65.55 | 2,642 | |
| 65.90 | -2.70 | -3.9% | 68.30 | 68.30 | 65.90 | 990 | |
| 68.60 | +1.90 | +2.8% | 67.10 | 68.60 | 66.70 | 508 | |
| 66.70 | +2.05 | +3.2% | 64.65 | 66.70 | 64.65 | 2,746 | |
| 64.65 | -1.05 | -1.6% | 66.60 | 66.60 | 64.65 | 258 | |
| 65.70 | +0.40 | +0.6% | 64.80 | 65.80 | 64.80 | 1,123 | |
| 65.30 | -0.10 | -0.2% | 66.05 | 66.05 | 64.60 | 1,124 | |
| 65.40 | -0.40 | -0.6% | 65.90 | 66.41 | 65.40 | 177 | |
| 65.80 | +0.50 | +0.8% | 65.65 | 66.00 | 64.50 | 1,189 | |
| 65.30 | -1.25 | -1.9% | 66.80 | 66.85 | 65.30 | 581 | |
| 66.55 | -0.25 | -0.4% | 66.75 | 66.75 | 66.55 | 79 | |
| 66.80 | -0.90 | -1.3% | 66.50 | 67.30 | 66.50 | 9,627 | |
| 67.70 | -2.20 | -3.1% | 68.20 | 68.60 | 67.40 | 267 | |
| 69.90 | +3.50 | +5.3% | 67.50 | 70.10 | 67.50 | 503 | |
| 66.40 | -2.40 | -3.5% | 67.80 | 67.80 | 66.40 | 190 | |
| 68.80 | +0.30 | +0.4% | 69.00 | 69.00 | 68.70 | 241 | |
| 68.50 | -0.60 | -0.9% | 69.20 | 69.20 | 68.40 | 411 | |
| 69.10 | -0.10 | -0.1% | 69.00 | 69.10 | 69.00 | 1,474 | |
| 69.20 | +1.30 | +1.9% | 68.55 | 69.20 | 68.55 | 34 | |
| 67.90 | -1.40 | -2.0% | 69.20 | 69.20 | 67.40 | 694 | |
| 69.30 | -0.001 | 0.0% | 69.00 | 70.40 | 69.00 | 2,699 | |
| 69.30 | +0.308 | +0.4% | 69.20 | 69.90 | 69.00 | 25,003 | |
| 68.99 | +2.543 | +3.8% | 67.30 | 69.00 | 67.30 | 4,887 | |
| 66.45 | +1.05 | +1.6% | 67.30 | 67.30 | 66.30 | 3,043 | |
| 65.40 | -0.864 | -1.3% | 65.80 | 66.10 | 64.85 | 5,286 | |
| 66.26 | +0.064 | +0.1% | 67.80 | 67.80 | 65.40 | 6,996 | |
| 66.20 | +1.451 | +2.2% | 64.40 | 66.70 | 64.40 | 4,543 | |
| 64.75 | -0.048 | -0.1% | 64.50 | 64.85 | 64.30 | 3,239 | |
| 64.80 | +0.304 | +0.5% | 63.40 | 64.80 | 63.40 | 1,914 | |
| 64.49 | +1.794 | +2.9% | 63.30 | 64.50 | 62.91 | 2,708 | |
| 62.70 | -1.704 | -2.6% | 62.40 | 64.00 | 62.40 | 197,031 | |
| 64.40 | -1.121 | -1.7% | 65.10 | 65.10 | 64.10 | 8,983 | |
| 65.53 | -0.635 | -1.0% | 66.50 | 66.50 | 65.50 | 7,238 | |
| 66.16 | +2.86 | +4.5% | 65.60 | 67.20 | 65.05 | 11,902 | |
| 63.30 | +0.055 | +0.1% | 63.60 | 63.72 | 62.60 | 10,358 | |
| 63.24 | -2.051 | -3.1% | 63.90 | 64.12 | 62.60 | 8,336 | |
| 65.30 | -0.521 | -0.8% | 65.70 | 65.90 | 64.50 | 21,508 | |
| 65.82 | +0.017 | 0.0% | 65.50 | 66.50 | 65.40 | 11,718 | |
| 65.80 | +0.83 | +1.3% | 65.90 | 66.50 | 65.20 | 120,081 | |
| 64.97 | +0.918 | +1.4% | 65.40 | 65.60 | 64.20 | 11,291 | |
| 64.05 | -0.442 | -0.7% | 64.20 | 64.80 | 63.70 | 25,646 | |
| 64.49 | -0.021 | 0.0% | 65.90 | 65.90 | 63.80 | 11,504 | |
| 64.51 | +4.527 | +7.5% | 63.00 | 64.70 | 63.00 | 23,178 | |
| 59.99 | +1.64 | +2.8% | 58.40 | 62.49 | 58.30 | 5,537 | |
| 58.35 | +4.146 | +7.6% | 58.00 | 59.60 | 57.54 | 9,353 |
- Ticker
- LSE:0QNA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- LSE
- Currency
- CHF
What changed lately
Latest news release · Oct 27, 2026
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
Latest earnings call · Aug 18, 2026
Basilea Pharmaceutica (SIX Swiss: BSLN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 42 slides
Calls
Replays
Basilea Pharmaceutica (SIX Swiss: BSLN) Q2 2026 Earnings Call
Tue, Aug 18, 2026 · 10:00 AM ET
Watch Transcript
Latest news
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
Oct 27, 2026
Closed 72.50 (+4.6%) on Oct 27, 2026
Basilea reports presentation of new data for fosmanogepix, isavuconazole and ceftobiprole at IDWeek 2026
Oct 20, 2026
Closed 67.85 (+2.2%) on Oct 20, 2026
Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
Sep 14, 2026
Closed 66.26 (+0.1%) on Sep 14, 2026
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
Aug 18, 2026
Closed 58.35 (+7.6%) on Aug 18, 2026
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
Aug 5, 2026
Closed 50.81 (+0.6%) on Aug 5, 2026
Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
Jul 29, 2026
Closed 52.76 (+0.8%) on Jul 29, 2026
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
May 28, 2026
Closed 52.50 (-2.4%) on May 28, 2026
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
Apr 15, 2026
Closed 55.80 (-1.8%) on Apr 16, 2026
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
Apr 9, 2026
Closed 53.85 (+0.3%) on Apr 9, 2026
Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
Mar 23, 2026
Closed 51.50 (-1.6%) on Mar 23, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 42 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 43 slides · Oct 1, 2026
H1 2026 Earnings Presentation
Earnings · 70 slides · Aug 18, 2026
H1 2026 Earnings Presentation
Earnings · 29 slides · Aug 18, 2026
Basilea Pharmaceutica AG on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 19 in the last 12 months · 32 in all · newest Oct 27, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Aug 18, 2026
- Decks
- 5 decks · latest Oct 27, 2026
Where Basilea Pharmaceutica AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:BSLN · Home listing | SIX Swiss | Switzerland | CHF |
| LSE:0QNA · This page | LSE | United Kingdom | CHF |
| gettex:PK5 | gettex | Germany | EUR |
| Aquis:BSLNZ | Aquis | United Kingdom | CHF |
| OTC:BPMUF | OTC | United States | USD |
| Lang & Schwarz:A0B9GA | Lang & Schwarz | Germany | EUR |
| LS Exchange:A0B9GA | LS Exchange | Germany | EUR |
| Tradegate:PK5 | Tradegate | Germany | EUR |
| BX Swiss:PK5 | BX Swiss | Switzerland | CHF |
| Munich:PK5 | Munich | Germany | EUR |
| Turquoise:BSLNZ | Turquoise | United Kingdom | CHF |
| Dusseldorf:PK5 | Dusseldorf | Germany | EUR |
| Frankfurt:PK5 | Frankfurt | Germany | EUR |
| Hamburg:PK5 | Hamburg | Germany | EUR |
| Stuttgart:PK5 | Stuttgart | Germany | EUR |
| Hanover:PK5 | Hanover | Germany | EUR |
| Xetra:PK5 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Basilea Pharmaceutica AG.